🇺🇸 GLP-1 analogue in United States

GLP-1 analogue (GLP-1 analogue) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

GLP-1 analogue in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is GLP-1 analogue approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for GLP-1 analogue in United States?

Tanabe Pharma Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.